All In MedTech

Device Trial Radar · NCT01824407

A Comparison of the dermaPACE® (Pulsed Acoustic Cellular Expression) Device in Conjunction With Standard of Care Versus Standard of Care Alone in the Treatment of Diabetic Foot Ulcers

A Double-Blind, Multi-center, Randomized, Sham-Controlled, Parallel Group Comparison of the dermaPACE® (Pulsed Acoustic Cellular Expression) Device in Conjunction With Standard of Care Versus Standard of Care Alone in the Treatment of Diabetic Foot Ulcers

Last checked: Nov 19, 2026Latest source record: Mar 6, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

90

Planned (sponsor's estimate)

Start

Mar 2013

Primary completion

Apr 2014

Sponsor

Lead sponsor
SANUWAVE, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Apr 4, 2013

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The Sponsor of this study, SANUWAVE, Inc., has developed an investigational device known as the dermaPACE® (Pulsed Acoustic Cellular Expression) device for the possible treatment of diabetic foot ulcers. This device generates acoustic (sound) pressure waves designed to act on the cells in your body to generate proteins that may lead to wound closure. The dermaPACE® device has not been approved for the treatment of diabetic foot ulcers; therefore its use in this study is investigational. The purpose of the study is to evaluate the ability of the dermaPACE® device to help diabetic foot ulcers heal more quickly. The active study device, the dermaPACE®, will be compared to an inactive look-alike device (called a "Sham") in this study. The sham device will not provide any treatment to your diabetic foot ulcer.

Conditions

  • Diabetic Foot Ulcers

Interventions

  • Electrohydraulic-generated shock waveDevice

  • Sham device plus standard of careDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Complete closureTime frame: 12 weeks

Locations

19 sites in 2 countries. Site status is shown where the registry gives one.

  • Associated Foot and Ankle Specialists

    Phoenix, Arizona · Recruiting

  • Southern Arizona VA Healthcare System

    Tucson, Arizona · Recruiting

  • Long Beach VA Healthcare System

    Long Beach, California · Recruiting

16 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.